New CDC Data Show Increased Cardiovascular Event Risks Within 12 Months Post-COVID-19 Among Men

By Helen Whitaker

U.S. surveillance data link prior COVID-19 infection to higher rates of new cardiovascular conditions in men during the following year. A large cohort study documented rises in ischemic heart disease, heart failure, arrhythmias, and thromboembolic events among men who had recovered from the virus compared with uninfected controls. The CDC's review of health care records found these risks peaked in the first 30 days after infection yet stayed measurable through 12 months. Men with severe initial illness faced the largest increases, though elevations appeared even among those with milder cases.

Types of cardiovascular events reported

Men experienced higher incidence of myocarditis and pericarditis in the weeks after SARS-CoV-2 infection. CDC case surveillance recorded the greatest rates of these conditions among men aged 18 to 29. Broader cohort findings also showed increases in myocardial infarction, heart failure, and various arrhythmias within the 12-month window.

Duration of elevated risk

The MMWR analysis of post-COVID conditions indicated that new or persistent cardiovascular symptoms such as chest pain and palpitations occurred most often in the first month. Risk for documented events remained above baseline levels for up to a year in the Nature Medicine cohort.

Subgroups with higher observed risk

Older men and those with pre-existing diabetes or obesity showed further risk elevation. Hospitalization during acute infection correlated with the largest absolute increases, but non-hospitalized men still recorded measurable excess events.

What this means

Observational records point to cardiovascular complications as one component of post-acute effects after COVID-19 in men. Patterns appear consistent across large U.S. data sets yet vary by age, illness severity, and prior health status.

Key takeaways

• A 2022 U.S. cohort study found significant rises in ischemic heart disease, heart failure, arrhythmias, and thromboembolic events among men in the 12 months after COVID-19 recovery [1].
• CDC surveillance through 2021 showed cardiovascular symptoms peaked within 30 days yet persisted in a subset of survivors up to one year [2].
• Myocarditis rates increased most among men aged 18 to 29 in the weeks following infection [3].
• Risk grew further with severe acute illness or existing cardiovascular risk factors, though absolute increases stayed modest in younger healthy groups.
• All findings derive from electronic health records and remain subject to under-ascertainment of mild cases.

Limitations

Most evidence comes from observational designs that cannot establish direct causation. Electronic records may miss undiagnosed or mild events. Few analyses separate risk by race, income, or vaccination status. Absolute risk increments for younger men without comorbidities stay small.